How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...
Recent insider activity at Recursion Pharmaceuticals consisted of 1 tax payment transaction by Ben R Taylor totaling $18,400.36. All reported activity was a single non-anomalous transaction on ...